Medical cannabis producer Aurora hires biopharmaceutical veteran Faris El Refaie to spearhead international growth and commercial operations.

Seun and Femi Kuti reflect on their father’s ritual cannabis use, state persecution, and his Early Influence Award—offering lessons for today’s cannabis culture.

Cannabis beverages are growing fast, but trust lags behind. Here’s how independent real‑world research can strengthen products, retail adoption, and delivery models.

Psychedelic Alpha reports that two psychiatrists in New Zealand have been cleared to prescribe MDMA for PTSD. Here’s what happened and what DMV readers should know.

NORML’s op-ed argues cannabis does not share the health risks of heroin, cigarettes, or alcohol and calls for removing it from Schedule I. Here’s what that stance means.

Psychedelic Science Review reports a rapid rise in psilocybin interest, with 100+ clinical trials since the early 2000s and recent studies signaling strong therapeutic potential.

MJBizDaily reports Texas rejected a hemp THC ban, yet subsequent state actions appear more restrictive. We unpack the policy signals and delivery-law takeaways for compliance teams.

Federal survey data shows 20% of older adults consumed cannabis in the past year, seeking alternatives to prescription drugs like opioids.

A study reported by Psychedelic Science Review examines norpsilocin derivatives and the potential role of monoalkyl tryptamines.

Discover how interning with NORML builds hands-on skills in cannabis policy, legal reform, and grassroots advocacy for future industry leaders.

New Cannabis Ventures reports that Vanguard has expanded its AI capabilities. Here’s how that business move could shape cannabis delivery compliance and licensing workflows in the DMV.

Researchers have experimentally shown that psilacetin (4‑AcO‑DMT) converts to psilocin in animals, resolving a long-running question about its metabolic fate.

Psychedelic Alpha reports that Risk Evaluation and Mitigation Strategies are likely to shape how FDA-approved psychedelic therapies are delivered. Here’s what to watch.

An Oklahoma extraction facility owner faces murder charges following a fatal blast, spotlighting safety and supply chain risk.

A deep dive into Ren and Chris Webby's collaborative album Asylum, examining its studio lore, pharmaceutical commentary, and scientific themes.

NCIA's 14th Lobbying Days arrived on the heels of the DOJ's April order moving state-regulated medical cannabis to Schedule III. Here's what Congress heard—and what DMV-area consumers and delivery operators should watch.

Psychedelic Science Review updates five years of research on gender-dependent psychedelic effects, female hormones, and 5-HT2A receptors.

Psychedelic Alpha’s Field Notes #4 flags active policy and access signals. Here’s why DMV cannabis delivery operators and consumers should care—and what to watch next.

Ohio producer Klutch Cannabis expands retail operations in Grandview while relocating its flagship Akron storefront for growth.

An in-depth look at Bulgarian artist Zdravko Zdravkov's vintage digital collage work, showcased by Cannabis Now and framing modern weed culture.